These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37120550)

  • 1. G-FORCE: the effectiveness of group psychotherapy for Cluster-C personality disorders: protocol of a pragmatic RCT comparing psychodynamic and two forms of schema group therapy.
    van den Heuvel BB; Dekker JJM; Daniëls M; Van HL; Peen J; Bosmans J; Arntz A; Huibers MJH
    Trials; 2023 Apr; 24(1):300. PubMed ID: 37120550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual psychotherapy for cluster-C personality disorders: protocol of a pragmatic RCT comparing short-term psychodynamic supportive psychotherapy, affect phobia therapy and schema therapy (I-FORCE).
    Daniëls M; Van HL; van den Heuvel B; Dekker JJM; Peen J; Bosmans J; Arntz A; Huibers MJH
    Trials; 2023 Apr; 24(1):260. PubMed ID: 37020251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of an RCT on cost-effectiveness of group schema therapy versus individual schema therapy for patients with Cluster-C personality disorder: the QUEST-CLC study protocol.
    Groot IZ; Venhuizen ASM; Bachrach N; Walhout S; de Moor B; Nikkels K; Dalmeijer S; Maarschalkerweerd M; van Aalderen JR; de Lange H; Wichers R; Hollander AP; Evers SMAA; Grasman RPPP; Arntz A
    BMC Psychiatry; 2022 Oct; 22(1):637. PubMed ID: 36209067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy.
    Kool M; Van HL; Bartak A; de Maat SCM; Arntz A; van den Eshof JW; Peen J; Blankers M; Bosmans JE; Dekker JJM
    BMC Psychiatry; 2018 Aug; 18(1):252. PubMed ID: 30086730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group schema-focused therapy enriched with psychomotor therapy versus treatment as usual for older adults with cluster B and/or C personality disorders: a randomized trial.
    van Dijk SDM; Veenstra MS; Bouman R; Peekel J; Veenstra DH; van Dalen PJ; van Asselt ADI; Boshuisen ML; van Alphen SPJ; van den Brink RHS; Oude Voshaar RC
    BMC Psychiatry; 2019 Jan; 19(1):26. PubMed ID: 30646879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group schema therapy for cluster-C personality disorders: A multicentre open pilot study.
    Wibbelink CJM; Venhuizen ASM; Grasman RPPP; Bachrach N; van den Hengel C; Hudepohl S; Kunst L; de Lange H; Louter MA; Matthijssen SJMA; Schaling A; Walhout S; Wichers KR; Arntz A
    Clin Psychol Psychother; 2023; 30(6):1279-1302. PubMed ID: 37691135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group schema therapy versus group cognitive behavioral therapy for social anxiety disorder with comorbid avoidant personality disorder: study protocol for a randomized controlled trial.
    Baljé A; Greeven A; van Giezen A; Korrelboom K; Arntz A; Spinhoven P
    Trials; 2016 Oct; 17(1):487. PubMed ID: 27717405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term intensive psychodynamic group therapy versus cognitive-behavioral group therapy in day treatment of anxiety disorders and comorbid depressive or personality disorders: study protocol for a randomized controlled trial.
    Suszek H; Holas P; Wyrzykowski T; Lorentzen S; Kokoszka A
    Trials; 2015 Jul; 16():319. PubMed ID: 26220089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personality disorder moderates outcome in short- and long-term group analytic psychotherapy: A randomized clinical trial.
    Lorentzen S; Ruud T; Fjeldstad A; Høglend PA
    Br J Clin Psychol; 2015 Jun; 54(2):129-46. PubMed ID: 25178520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group schema therapy combined with psychomotor therapy for older adults with a personality disorder: an open-label, multicentre, randomised controlled trial.
    Veenstra-Spruit MS; Bouman R; van Dijk SD; van Asselt AD; van Alphen SP; Veenstra DH; de Ruiter M; Troost SE; Lammers MW; Vulker F; Smeets-Janssen MM; van den Brink RH; Voshaar RCO
    Lancet Healthy Longev; 2024 Apr; 5(4):e245-e254. PubMed ID: 38555919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of an international multicentre RCT on group schema therapy for borderline personality disorder.
    Wetzelaer P; Farrell J; Evers SM; Jacob GA; Lee CW; Brand O; van Breukelen G; Fassbinder E; Fretwell H; Harper RP; Lavender A; Lockwood G; Malogiannis IA; Schweiger U; Startup H; Stevenson T; Zarbock G; Arntz A
    BMC Psychiatry; 2014 Nov; 14():319. PubMed ID: 25407009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Day Treatment Group Schema Therapy for Personality Disorders: A Multiple Baseline Single-Case Study.
    van Houten J; Bouwmeester S; Bachrach N
    Clin Psychol Psychother; 2024; 31(2):e2964. PubMed ID: 38528762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group schema therapy for patients with cluster-C personality disorders: A case study on avoidant personality disorder.
    Bachrach N; Arntz A
    J Clin Psychol; 2021 May; 77(5):1233-1248. PubMed ID: 33538340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards optimal treatment selection for borderline personality disorder patients (BOOTS): a study protocol for a multicenter randomized clinical trial comparing schema therapy and dialectical behavior therapy.
    Wibbelink CJM; Arntz A; Grasman RPPP; Sinnaeve R; Boog M; Bremer OMC; Dek ECP; Alkan SG; James C; Koppeschaar AM; Kramer L; Ploegmakers M; Schaling A; Smits FI; Kamphuis JH
    BMC Psychiatry; 2022 Feb; 22(1):89. PubMed ID: 35123450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trauma-focused EMDR for Personality disorders among Outpatients (TEMPO): study protocol for a multi-centre, single-blind, randomized controlled trial.
    Hofman S; Hafkemeijer L; de Jongh A; Starrenburg A; Slotema K
    Trials; 2022 Mar; 23(1):196. PubMed ID: 35246228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schema therapy versus treatment as usual for outpatients with difficult-to-treat depression: study protocol for a parallel group randomized clinical trial (DEPRE-ST).
    Arendt ITP; Gondan M; Juul S; Hastrup LH; Hjorthøj C; Bach B; Videbech P; Jørgensen MB; Moeller SB
    Trials; 2024 Apr; 25(1):266. PubMed ID: 38627837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a multicentered randomized controlled trial on the clinical and cost effectiveness of schema therapy for personality disorders.
    Bamelis LL; Evers SM; Arntz A
    BMC Public Health; 2012 Jan; 12():75. PubMed ID: 22272740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders.
    Bamelis LL; Evers SM; Spinhoven P; Arntz A
    Am J Psychiatry; 2014 Mar; 171(3):305-22. PubMed ID: 24322378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT.
    Kopf-Beck J; Zimmermann P; Egli S; Rein M; Kappelmann N; Fietz J; Tamm J; Rek K; Lucae S; Brem AK; Sämann P; Schilbach L; Keck ME
    BMC Psychiatry; 2020 Oct; 20(1):506. PubMed ID: 33054737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.